912 related articles for article (PubMed ID: 26522484)
1. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
2. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
3. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
4. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
5. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
7. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
8. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
9. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
11. [Use of sulprostone in the evacuation of molar pregnancies].
Pinet C; Colau JC
Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
[TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic disease.
Gerulath AH; Ehlen TG; Bessette P; Jolicoeur L; Savoie R; ; ;
J Obstet Gynaecol Can; 2002 May; 24(5):434-46. PubMed ID: 12196865
[TBL] [Abstract][Full Text] [Related]
13. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
[TBL] [Abstract][Full Text] [Related]
15. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
16. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
18. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
19. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
Hirashima N
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
